Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xinbao Pill
- Development stage
- Unknown
- Lead developer
- Guangdong Xinbao Pharmaceutical
- Administration
- Oral
01
Overview
Xinbao Pill (Xinbao Wan) is a Traditional Chinese Medicine (TCM) formulation developed and manufactured by Guangdong Taiantang Pharmaceutical. It is primarily indicated for the treatment of chronic heart failure (CHF), bradycardia, and sick sinus syndrome, particularly in patients diagnosed with Heart-Kidney Yang Deficiency syndrome according to TCM principles. The pill is composed of several potent herbal and animal-derived ingredients, including *Panax ginseng*, *Aconitum carmichaelii* (processed), *Cervus elaphus* (deer antler), *Cinnamomum cassia*, and *Bufonis Venenum* (toad venom), among others. Its pharmacological effects include increasing cardiac output, improving coronary blood flow, and enhancing the self-discipline of the sinoatrial node. In clinical practice, it is often used as an adjunctive therapy to improve symptoms and quality of life in patients with refractory heart failure or slow heart rates.
- Brand names
- Xinbao PillXinbao Wan
- Other names
- Xinbao Wan
02
Targets
PRKAA1 (AMP-activated protein kinase alpha catalytic subunit isoform alpha-1)GSK3 (Glycogen synthase kinase 3 beta)PIK3CA (Phosphoinositide 3-kinase alpha)
Beyond the preview
Go deeper on Xinbao Pill.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xinbao Pill.